Tokyo, Japan

Shuichiro Yamanaka

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:

goldMedal2 out of 3 
 
Bios Co., Ltd
 patents
silverMedal2 out of 832,880 
Other
 patents
where one patent can have more than one assignee

Years Active: 2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Shuichiro Yamanaka: Innovator in Kidney Production Methods

Introduction

Shuichiro Yamanaka is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of regenerative medicine, particularly in the area of kidney production. With a total of 2 patents, Yamanaka's work is paving the way for innovative solutions in organ transplantation.

Latest Patents

Yamanaka's latest patents focus on methods for producing kidneys. The first patent describes a kidney production method that includes a step of tissue-specifically removing a metanephric mesenchyme from a metanephros of a non-human animal. This method also involves transplanting a human kidney precursor cell into the metanephros and advancing the development of the metanephros, allowing the transplanted human kidney precursor cell to differentiate and mature into part of the kidney. The second patent outlines a similar kidney production method, but it involves transplanting a kidney precursor cell derived from a non-human animal that is allogeneic or xenogeneic to the non-human animal. This method also includes steps for advancing the development of the metanephros.

Career Highlights

Throughout his career, Yamanaka has worked with various organizations, contributing his expertise to the field of regenerative medicine. His innovative approaches have garnered attention and respect within the scientific community.

Collaborations

Yamanaka has collaborated with notable individuals in his field, including Takashi Yokoo. Their joint efforts have further advanced the research and development of kidney production methods.

Conclusion

Shuichiro Yamanaka's contributions to kidney production methods represent a significant advancement in regenerative medicine. His innovative patents and collaborations highlight the potential for future breakthroughs in organ transplantation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…